Amgen
The Director, Scientific and Operations Intelligence, Obesity leads the non‑commercial obesity insights and analytics agenda across scientific and operational functions at Amgen. Acting as a trusted partner to senior leaders, the role defines high‑impact questions, mobilizes data and expertise, and delivers actionable recommendations to improve decisions and outcomes. The position also builds the long‑term team, operating model, and analytical capabilities to sustain value creation.
Headquarters
Thousand Oaks, California, United States
Company Size
10001+ employees
Founded
1980
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Amgen.
22% above the average for this role
Gilead Gets a Buy, Amgen a Hold and ORIC a Vote of Confidence: Wall Street's Latest Biopharma Calls Explained
1 day ago
Executive Director, Obesity, Analytics & Forecasting
lifelancer
Sr Manager, Global Scientific Communications & Engagement Strategy– Obesity
lifelancer
Director, Obesity and Metabolic Diseases
Merck & Co., Inc.
Senior Director, Obesity Discovery Research
AbbVie
Medical Scientific Liaison-Hematology
Novartis
Senior Medical Science Liaison - Obesity - NY
lifelancer